Marco Pugliese

MARCO PUGLIESE Director Marco Pugliese co-founded Neurotec Pharma on 2006 aiming to develop a treatment for CNS diseases, specially focusing on inflammation and neurodegeneration. From 2008 to 2014 worked as CEO, achieving the main goal of carrying a multi-centre and international Phase II research with 110 RR-Multiple Sclerosis patients. From 2014 to 2015 worked as…

Martín Tribaldos Fernández

MARTÍN TRIBALDOS FERNÁNDEZ Communication Responsible   Martín has a Bachelor’s Degree in Communication and Cultural Industries from the University of Barcelona, and an interuniversity Master’s Degree in Communication from the Pompeu Fabra University. Journalist, he has worked in La Vanguardia and in communication and public relations consultancies. Check his CV on LinkedIn.  

Cristina Espallargas

CRISTINA ESPALLARGAS Communications Director With studies in Pedagogy and Communication sciences, Cristina began her career as a radio journalist and moved after to the media consultancy sector, where she has been for more than 20 years. As a consultant, she has worked in Grayling, Citigate Sanchis and Shandwick, among others, developing PR & Communication plans…

Marco Pugliese

MARCO PUGLIESE Director Marco Pugliese co-founded Neurotec Pharma on 2006 aiming to develop a treatment for CNS diseases, specially focusing on inflammation and neurodegeneration. From 2008 to 2014 worked as CEO, achieving the main goal of carrying a multi-centre and international Phase II research with 110 RR-Multiple Sclerosis patients. From 2014 to 2015 worked as…

AP-01 Project

Ankar Pharma worked to develop new therapies to improve the quality of life of the patients Ankar Pharma is a spin-off from the Scientific Investigation Superior Council (CSIC in Spanish), which mission is to develop new therapies that find a cure or improve the quality of life of multiple sclerosis patients. It joined the GAEM…

Marco Pugliese, new managing director of GAEM Foundation

GAEM Foundation reinforces its team with the incorporation as director of Marco Pugliese, expert in innovation in the field of health. Professor of Biochemistry and Molecular Biology at the University of Barcelona, Marco will contribute with his experience and talent to boost GAEM Foundation research projects to cure multiple sclerosis and improve the quality of life of MS sufferers.